Seminar Detail

2019 Psychopharmacology 2-Day Conference
2019 Psychopharmacology 2-Day Conference

Where:   TARENTUM, PA

When:  Thursday, October 31, 2019 - Friday, November 1, 2019

This event is not currently available for purchase.

For more information: Call (800) 844-8260
Course Description:

Spend two action-packed days learning about the newest advances in psychopharmacology and contemporary trends in medication management. From his unique perspective, Dr. Perry Buffington teaches psychopharmacology thoughtfully, with an emphasis on the experience of the client. Dr. Buffington’s years of experience in mental health and passion for clients, shines through in the detail and thoroughness of his presentation.

Clients often only have a few minutes with their prescriber and require additional support. It’s vital that you are able to answer their questions, help manage side effects and understand reactions. Designed for counselors, nurses, psychotherapists, psychologists, and other mental health professionals, Dr. Buffington provides the information you need in order to best help your clients.

This conference allows time for exploration of underrepresented areas, including ADHD, substance use disorders and psychopharmacological ethics. Take home specialized guidelines for geriatrics, and clients with chronic pain. Discuss how the DSM-5® and the Affordable Healthcare Law have impacted prescribing patterns and the use of psychotropics in newly defined diagnoses. In addition to a general ‘nuts and bolts’ review of medications, you will examine case examples, discuss medication controversies and how to effectively collaborate with prescribing practitioners. You will find this conference to have the most up-to-date medication information and how to use it most effectively with your client.
Objectives:

  1. Analyze the historical antecedents of psychopharmacological products and their relation to today’s psychotropic medications.
  2. Designate the mechanism of action of today’s psychotropic medications and how it relates to your clients.
  3. Breakdown the process of medication selection and receptor activation//blocking for specific disorders.
  4. Communicate the side effects including nutritional, cognitive, sexual, and behavioral associated with psychotropic medications.
  5. Specify how medications are chosen for mood disorders and specific patient characteristics.
  6. Compile medication treatment options for your clients with ADHD.
  7. Determine the unique medication considerations for geriatric clients.
  8. Determine acute and chronic pain and methods of treatment.
  9. Analyze future trends, including preventing side effects vs. managing side effects.
  10. Establish ethical issues specifically relating to the child and adolescent population as it relates to clinical psychopharmacology.
  11. Apply traditional standards (autonomy, beneficence, nonmaleficence, confidentiality, veracity) of ethical behavior to issues peculiar to the practice of clinical psychopharmacology.
  12. Explore specific ethical issues and their resolve to the everyday practice of clinical psychopharmacology.
OUTLINE

DAY ONE

Psychopharmacology
  • Historical antecedents of modern psychopharmacology
  • Diagnostic issues
  • Clarification of terms
  • Drug metabolism concepts: pharmacokinetics & pharmacodynamics
  • Drug mechanism of action
  • Placebo & Nocebo
  • Pharmacotherapy vs. Pharmacotherapy
  • Developing highly effective collaborations with prescribers
Depressive Disorders
  • Biogenic Amine, Cortisol, Down-Regulation, & Neurotropic Hypotheses
  • Neurochemistry of depression
  • Types of anti-depressants
  • Preventing side effects
  • Tardive Dysphoria: real or imagined?
Anxiety Disorders & Obsessive Compulsive Disorders & Trauma Related Disorders
  • Neurochemistry of anxiety
  • GAD, panic disorders, phobias
  • OCD
  • PTSD
  • Physiological interventions
  • Anti-anxiety medications
    • Anti-depressants
  • Non-pharmacologic options
  • Benzodiazepines: risks and benefits
  • Preventing side effects
Bipolar Disorders
  • Neurochemistry
  • The Bipolar Spectrum & DSM-5® Changes
  • Mood stabilizers
    • Lithium
    • Anti-convulsants & neuromodulators
  • Typical, atypical, & third-generation antipsychotics
  • Effective strategies for improving outcomes for clients
Psychotic Disorders/Schizophrenia
  • Neurochemistry of psychosis and schizophrenia
  • Antipsychotic Medications:
    • First generation (typical)
    • Second generation (atypical)
  • Managing side effects
    • Extrapyramidal symptoms and TD
    • Metabolic problems – what blood tests are needed and when
    • Preventing Diabetes Mellitus
  • Recognizing hyperprolactinemia – and why you need to know
  • Use of atypical antipsychotics for multiple disorders
Limitations of the Research and Potential Risks

DAY TWO

Attentional Disorders
  • Differential diagnosis
  • Neurochemistry of ADHD
  • Treatment controversies
  • Substance abuse and ADHD
  • Stimulant medications
  • Non-stimulant options
  • Preventing side effects
Substance Abuse Disorders
  • Neurochemistry of addiction
  • Negative reinforcement & creation of habits
  • Alcohol
  • Caffeine
  • Nicotine
  • Cannabis
  • Opiates
  • PCP & Ketamine
  • MDMA (Ecstasy)
  • Energy vs. Chill Drinks
  • Over-the-counter & herbal psychopharmacology
  • Addiction treatments
  • Behavioral addictions
Special Populations
  • Specialized guidelines for geriatric patients
  • Dementia treatment
  • Slow vs. rapid metabolizers (genetic polymorphisms)
Treating Clients Pain
  • Acute vs. chronic pain
  • Alternatives to pharmacology
  • Pain vs. depression: which comes first?
Ethics & Psychopharmacology
  • High-risk pharmacology & psychopharmacology
  • Off-label use of medications
  • Prescribing for children
  • Elective psychopharmacology
  • Marketing of mental illness
  • Polypharmacy
  • Informed vs. uninformed consent
  • Patient & third party pressures
  • Professional boundaries
  • Ethics associated with medical errors
  • Role of placebo
Future Trends
  • Change of mind: preventing vs. managing side effects
  • Medicalization of normal
  • Computer assisted devices
  • New meds, new diagnoses, new theories, new normal
  • Top 10 Medical Emergencies
  • Integrating psychotherapy with psychopharmacology
Limitations of the Research and Potential Risks
Target Audience

  • Counselors
  • Social Workers
  • Psychologists
  • Psychotherapists
  • Psychiatrists
  • Physician Assistants
  • Case Managers
  • Marriage & Family Therapists
  • Physicians
  • Nurses
  • Nurse Practitioners
  • Clinical Nurse Specialists
  • Addiction Counselors
  • Pharmacists
  • Occupational Therapists
  • Occupational Therapy Assistants
  • Other Mental Health & HealthCare Professionals

PERRY W. BUFFINGTON, PH.D., MS

Perry Buffington, Ph.D., M.S., has over 20 years of experience in the medical consulting field and is currently a full-time senior lecturer at the University of Georgia, teaching psychopharmacology at the undergraduate and graduate levels. He is former chairman of the prestigious Florida Psychological Association’s Prescriptive Authority Committee and teaches seminars nationwide on minimizing psychopharmacological errors.

As the author of eight books (currently working on his first psychopharmacology text), his by-line has appeared in hundreds of periodicals including the Saturday Evening Post, USA Today, and Success. He is the former contributing editor for Delta Air Lines’ in-flight magazine, Sky, and served as a syndicated newspaper/web columnist for Universal Press. Additional, he hosted his own radio show, syndicated nationally, by Envison Radio Networks.

Perry’s presentation style is engaging, a blend of education and entertainment; as a result, critics (and especially his students) applaud his ability to make complicated topics understandable and applicable – even useful!!



Speaker Disclosures:

Financial: Perry Buffington is the President of Go-Buff Enterprises, Inc. He is a member of the psychology faculty, Franklin College of Arts & Sciences, The University of Georgia. Dr. Buffington receives a speaking honorarium from PESI, Inc.

Nonfinancial: Perry Buffington has no relevant nonfinancial relationship to disclose.
Credits listed below are for full attendance at the live event only. After attendance has been verified, pre-registered attendees will receive an email from PESI Customer Service with the subject line, “Evaluation and Certificate” within one week. This email will contain a link to complete the seminar evaluation and allow attendees to print, email or download a certificate of completion if in full attendance. For those in partial attendance (arrived late or left early), a letter of attendance is available through that link and an adjusted certificate of completion reflecting partial credit will be issued within 30 days (if your board allows). Please see “live seminar schedule” for full attendance start and end times. NOTE: Boards do not allow credit for breaks or lunch.

If your profession is not listed, please contact your licensing board to determine your continuing education requirements and check for reciprocal approval. For other credit inquiries not specified below, or questions on home study credit availability, please contact cepesi@pesi.com or 800-844-8260 before the event.

Materials that are included in this course may include interventions and modalities that are beyond the authorized practice of mental health professionals. As a licensed professional, you are responsible for reviewing the scope of practice, including activities that are defined in law as beyond the boundaries of practice in accordance with and in compliance with your professions standards.

PESI, Inc. offers continuing education programs and products under the brand names PESI, PESI Healthcare, PESI Rehab and Psychotherapy Networker.




Ethics
This seminar includes 3.0 hours of general ethics instruction. If ethics is not specified within your licensing board’s approval statement below, please contact your board to determine the applicability and amount of ethics allowed.


Addiction Counselors
This course has been approved by PESI, Inc., as a NAADAC Approved Education Provider, for 12.5 CE in the Counseling Services skill group. NAADAC Provider #77553. PESI, Inc. is responsible for all aspects of their programming. Full attendance is required; no partial credit will be awarded for partial attendance.

Ohio Chemical Dependency Professionals: This course has been approved by the Ohio Chemical Dependency Professionals Board for 12.5 CEUs.

Pennsylvania Addiction Counselors: This course has been reviewed and approved for by the Pennsylvania Certification Board. This course will award 12.5 PCB Approved Hours of Education. (Valid for PA locations only)


Counselors
This intermediate activity consists of 12.5 clock hours of continuing education instruction. Credit requirements and approvals vary per state board regulations. Please save the course outline, the certificate of completion you receive from the activity and contact your state board or organization to determine specific filing requirements.

Ohio Counselors: PESI, Inc. is an approved provider with the State of Ohio Counselor, Social Worker and Marriage & Family Therapist Board. Provider approval #:RCST071001. Full attendance at this course meets the qualifications for 12.5 clock hours of continuing education credit.

Pennsylvania Counselors: The Pennsylvania State Board of Social Workers, Marriage and Family Therapists and Professional Counselors accepts many national association CE approvals, several of which PESI offers. For a full list, please see your State Board regulations at https://www.dos.pa.gov/ProfessionalLicensing/BoardsCommissions/. This Intermediate activity consists of 12.5 clock hours of continuing education instruction.


Marriage & Family Therapists
This activity consists of 760 minutes of continuing education instruction. Credit requirements and approvals vary per state board regulations. You should save this course outline, the certificate of completion you receive from the activity and contact your state board or organization to determine specific filing requirements.

Ohio Marriage & Family Therapists: PESI, Inc. is an approved provider with the State of Ohio Counselor, Social Worker and Marriage & Family Therapist Board. Provider approval #:RCST071001. Full attendance at this course meets the qualifications for 12.5 clock hours of continuing education credit.

Pennsylvania Marriage & Family Therapists: The Pennsylvania State Board of Social Workers, Marriage and Family Therapists and Professional Counselors accepts many national association CE approvals, several of which PESI offers. For a full list, please see your State Board regulations at https://www.dos.pa.gov/ProfessionalLicensing/BoardsCommissions/. This Intermediate activity consists of 12.5 clock hours of continuing education instruction.


Nurses, Nurse Practitioners, and Clinical Nurse Specialists
American Nurses Credentialing Center Logo
PESI, Inc. is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

Nurses in full attendance will earn 12.6 contact hours. Partial contact hours will be awarded for partial attendance.


Occupational Therapists & Occupational Therapy Assistants
AOTA Logo
PESI, Inc. is an AOTA Approved Provider of continuing education. Provider #: 3322. Full attendance at this course qualifies for 12.5 contact hours or 1.25 CEUs in the Category of Domain of OT and Occupational Therapy Process. Partial credit will be issued for partial attendance. The assignment of AOTA CEUs does not imply endorsement of specific course content, products, or clinical procedures by AOTA. Course Level: Intermediate.


Pharmacists
ACPE Logo
PESI, Inc. is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. Successful completion of this Knowledge-based activity qualifies for 12.6 contact hours. ACPE Universal Program Number: 0289-0000-17-005-L01-P. Full attendance is required. No partial contact hours will be awarded for partial attendance. You are required to complete a program evaluation/post-test and bring your e-Profile ID to the seminar to receive CPE credit. Don’t have your e-Profile ID yet? Visit the National Association of Boards of Pharmacy (NABP) website and complete your e-profile at www.nabp.net in order to obtain your NABP e-Profile ID.


Physician Assistants
AAPA accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credits™ from organizations accredited by ACCME such as PESI. Physician assistants may receive a maximum of 12.5 hours for completing this program.

PESI, Inc. is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. PESI, Inc. designates this live activity for a maximum of 12.5 AMA PRA Category 1 Credits™.

Ohio Psychologists: CE credit is available. PESI, Inc. is approved by the Ohio Psychological Association, Provider #263896894, to sponsor continuing education for psychologists. PESI, Inc. maintains responsibility for this program and its content. PESI is offering this activity for 12.5 standard hours of continuing education credit. Full attendance is required; no partial credits will be offered for partial attendance.

Pennsylvania Psychologists: CE credit is available. PESI, Inc. is approved by the Pennsylvania State Board of Psychology to offer continuing education for psychologists. Provider #PSY000211. PESI maintains responsibility for the program(s). This program qualifies for 12.5 continuing education hours.


Social Workers
ASWB Logo
PESI, Inc., #1062, is approved to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Organizations, not individual courses, are approved as ACE providers. State and provincial regulatory boards have the final authority to determine whether an individual course may be accepted for continuing education credit. PESI, Inc. maintains responsibility for this course. ACE provider approval period: January 27, 2017 - January 27, 2020. Social Workers completing this course receive 9.5 Clinical Practice and 3.0 Ethics continuing education credits. No more than 12.5 total CE hours may be awarded for this activity. Course Level: Intermediate. Full attendance is required; no partial credits will be offered for partial attendance. A certificate of attendance will be awarded at the end of the program to social workers who complete the program evaluation.

Ohio Social Workers: PESI, Inc. is an approved provider with the State of Ohio Counselor, Social Worker and Marriage & Family Therapist Board. Provider approval #:RCST071001. Full attendance at this course meets the qualifications for 12.5 clock hours of continuing education credit.

Pennsylvania Social Workers: The Pennsylvania State Board of Social Workers, Marriage and Family Therapists and Professional Counselors accepts many national association CE approvals, several of which PESI offers. For a full list, please see your State Board regulations at https://www.dos.pa.gov/ProfessionalLicensing/BoardsCommissions/. This Intermediate activity consists of 12.5 clock hours of continuing education instruction.


Other Professions
This activity qualifies for 760 minutes of instructional content as required by many national, state and local licensing boards and professional organizations. Save your course outline and certificate of completion, and contact your own board or organization for specific requirements.

Credit Card Required for online registration | Contact us to redeem Gift Certificates